Developing the first effective drug for progressive MS

In Focus

A clinician/scientist at The Neuro played a major role in developing a drug that offers hope to people with two forms of multiple sclerosis (MS), including one where no other effective drug existed. 

Breakthrough in MS treatment

Research

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.